Literature DB >> 20588287

Glomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism?

Jeffrey B Kopp1.   

Abstract

Genetic variation in MYH9, encoding non-muscle heavy chain IIA, has been recognized for over a decade as the cause of an autosomal dominant syndrome characterized by macrothrombocytopenia, neutrophil inclusions, and glomerular pathology. More recently, genetic variation in the MYH9 region on chromosome 22 has been associated with chronic kidney disease in African-descent individuals. A better understanding of the disease mechanisms responsible for glomerular injury in autosomal dominant MYH9 syndromes will lead to fuller appreciation of the role of this gene in glomerular biology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20588287      PMCID: PMC3119358          DOI: 10.1038/ki.2010.82

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  23 in total

1.  End-stage renal disease in two pediatric patients with Fechtner syndrome.

Authors:  M M Moxey-Mims; G Young; A Silverman; D M Selby; J G White; K K Kher
Journal:  Pediatr Nephrol       Date:  1999-11       Impact factor: 3.714

2.  Fechtner syndrome--a variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopenia.

Authors:  L C Peterson; K V Rao; J T Crosson; J G White
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

3.  Hereditary macrothrombocytopathia, nephritis and deafness.

Authors:  C J Epstein; M A Sahud; C F Piel; J R Goodman; M R Bernfield; J H Kushner; A R Ablin
Journal:  Am J Med       Date:  1972-03       Impact factor: 4.965

4.  Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease.

Authors:  Takashi Sekine; Mutsuko Konno; Satoshi Sasaki; Suzuko Moritani; Takuma Miura; Wai-shan Wong; Hisanori Nishio; Toshihiro Nishiguchi; Miyako Yoshinari Ohuchi; Shigeru Tsuchiya; Takeshi Matsuyama; Hirokazu Kanegane; Komei Ida; Kenichiro Miura; Yutaka Harita; Motoshi Hattori; Shigeru Horita; Takashi Igarashi; Hidehiko Saito; Shinji Kunishima
Journal:  Kidney Int       Date:  2010-03-03       Impact factor: 10.612

5.  Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly.

Authors:  M J Kelley; W Jawien; T L Ortel; J F Korczak
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

6.  Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly/Fechtner syndrome.

Authors:  Samuel Deutsch; Alexandra Rideau; Marie-Luce Bochaton-Piallat; Giuseppe Merla; Antoine Geinoz; Giulio Gabbiani; Torsten Schwede; Thomas Matthes; Stylianos E Antonarakis; Photis Beris
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

7.  Alport's syndrome associated with macrothrombopathic thrombocytopenia.

Authors:  N M Clare; M M Montiel; M D Lifschitz; G A Bannayan
Journal:  Am J Clin Pathol       Date:  1979-07       Impact factor: 2.493

8.  Hereditary nephritis, platelet disorders and deafness-Epstein's syndrome.

Authors:  S Túri; J Kóbor; A Erdös; T Bodrogi; I Virág; J Ormos
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

9.  Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium.

Authors:  M Seri; R Cusano; S Gangarossa; G Caridi; D Bordo; C Lo Nigro; G M Ghiggeri; R Ravazzolo; M Savino; M Del Vecchio; M d'Apolito; A Iolascon; L L Zelante; A Savoia; C L Balduini; P Noris; U Magrini; S Belletti; K E Heath; M Babcock; M J Glucksman; E Aliprandis; N Bizzaro; R J Desnick; J A Martignetti
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

10.  Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome).

Authors:  Gian Marco Ghiggeri; Gianluca Caridi; Umberto Magrini; Adalberto Sessa; Anna Savoia; Marco Seri; Alessandro Pecci; Roberta Romagnoli; Simone Gangarossa; Patrizia Noris; Saverio Sartore; Vittorio Necchi; Roberto Ravazzolo; Carlo L Balduini
Journal:  Am J Kidney Dis       Date:  2003-01       Impact factor: 8.860

View more
  15 in total

1.  Advances in our understanding of the pathogenesis of HIV-1 associated nephropathy in children.

Authors:  Patricio E Ray; Chien-An A Hu
Journal:  Future Virol       Date:  2011-07       Impact factor: 1.831

Review 2.  Arrest of the true culprit and acquittal of the innocent? Genetic revelations charge APOL1 variants with kidney disease susceptibility.

Authors:  Martin Zenker; Peter R Mertens
Journal:  Int Urol Nephrol       Date:  2010-11-16       Impact factor: 2.370

Review 3.  Pathogenesis of glomerular haematuria.

Authors:  Claudia Yuste; Eduardo Gutierrez; Angel Manuel Sevillano; Alfonso Rubio-Navarro; Juan Manuel Amaro-Villalobos; Alberto Ortiz; Jesus Egido; Manuel Praga; Juan Antonio Moreno
Journal:  World J Nephrol       Date:  2015-05-06

Review 4.  African origins and chronic kidney disease susceptibility in the human immunodeficiency virus era.

Authors:  Alex N Kasembeli; Raquel Duarte; Michèle Ramsay; Saraladevi Naicker
Journal:  World J Nephrol       Date:  2015-05-06

Review 5.  MYH9: Structure, functions and role of non-muscle myosin IIA in human disease.

Authors:  Alessandro Pecci; Xuefei Ma; Anna Savoia; Robert S Adelstein
Journal:  Gene       Date:  2018-04-19       Impact factor: 3.688

Review 6.  The population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus.

Authors:  Saharon Rosset; Shay Tzur; Doron M Behar; Walter G Wasser; Karl Skorecki
Journal:  Nat Rev Nephrol       Date:  2011-05-03       Impact factor: 28.314

7.  Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A.

Authors:  Yingfan Zhang; Mary Anne Conti; Daniela Malide; Fan Dong; Aibing Wang; Yelena A Shmist; Chengyu Liu; Patricia Zerfas; Mathew P Daniels; Chi-Chao Chan; Elliot Kozin; Bechara Kachar; Michael J Kelley; Jeffrey B Kopp; Robert S Adelstein
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

8.  Renal manifestations of patients with MYH9-related disorders.

Authors:  Kyoung Hee Han; HyunKyung Lee; Hee Gyung Kang; Kyung Chul Moon; Joo Hoon Lee; Young Seo Park; Il Soo Ha; Hyo Seop Ahn; Yong Choi; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2011-01-06       Impact factor: 3.714

Review 9.  How benign is hematuria? Using genetics to predict prognosis.

Authors:  Daniel P Gale
Journal:  Pediatr Nephrol       Date:  2013-01-17       Impact factor: 3.714

Review 10.  The glomerular filtration barrier: a structural target for novel kidney therapies.

Authors:  Ilse S Daehn; Jeremy S Duffield
Journal:  Nat Rev Drug Discov       Date:  2021-07-14       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.